Skip to main content
Dermatology Reports logoLink to Dermatology Reports
. 2023 Aug 10;16(1):9745. doi: 10.4081/dr.2023.9745

Topical minoxidil reported hair discoloration: a cross-sectional study

Ghada Alhayaza 1,, Alanoud Hakami 2, Lenah H AlMarzouk 3, Abdullah A Al Qurashi 4,5, Ghada Alghamdi 3, Ruaa Alharithy 6,7
PMCID: PMC11017712  PMID: 38623369

Abstract

Minoxidil is a widely utilized medication androgenic alopecia. An original investigation on its potential to cause hair darkening in treated people is lacking. We conducted an observational study using two face-validated questionnaires that dermatologists altered to assess minoxidil’s hair discolouration risk. This Saudi Arabian survey collected data in October and November 2022. One questionnaire targeted the population, while the other targeted dermatologists. Survey 1 included 453 patients, 56.7% of whom were 18-24 and mostly female. It’s interesting that 26% (n=118) detected hair greying and 14.8% (n=67) noticed other color changes. With P-values of 0.0001, longer-term minoxidil users and those with a family history of hair greying had higher hair discolouration. Dermatologists completed Survey 2 (57 participants). Nearly 60% of dermatologists have ten years of experience. 42.1% of dermatologists saw grey hair after minoxidil use. 17.5% of doctors blame minoxidil for hair graying. This observational study examined the data of over 400 patients to determine if minoxidil could cause hair discoloration. Based on the data, we hypothesize that this drug may cause hair discoloration with prolonged use and in people with a family history of hair greying.

Key words: Minoxidil, alopecia, hair discoloration

Introduction

Minoxidil belongs to the vasodilator medication class, and it was first approved in the 1970s as an antihypertensive drug indicated for refractory hypertension.1 However, due to one of its adverse effects, hypertrichosis, topical formulations were introduced to stimulate and enhance hair growth and slow hair thinning.2

The mechanism of action of minoxidil has yet to be fully understood, but it is thought to work by vasodilatory effects. It activates the vascular endothelial growth factor, increasing cutaneous blood flow, oxygen, and growth factor delivery to the hair follicle.3 It also leads to potassium channel activation in the hair follicles, which prolongs the anagen phase and shortens the telogen phase.4

Topical minoxidil is the mainstay treatment for androgenetic alopecia (AGA). However, it is also an off-label treatment for many hair disorders, including alopecia areata, chemotherapyinduced alopecia, frontal fibrosing alopecia, telogen effluvium, and loose anagen hair syndrome.2

While minoxidil has been used for decades to increase the rate of hair growth and prevent hair loss in patients, this study aims to investigate a phenomenon witnessed in practice with limited reports in the literature, which is the effect of minoxidil on hair color changes.

Materials and Methods

Study design

A cross-sectional study was done using two anonymous self-administered questionnaires designed in the Survey Monkey tool (Survey Monkey Inc.); the first was for the general population, and the second was for dermatologists. It was distributed in the dermatology clinic and on social media platforms such as Twitter, Snap Chat, Instagram, and WhatsApp. Data was collected between October-November 2022.

Table 1.

Characteristics of the participants (n=453).

Variables Number %
Age under 18 years
   16 3.5
   18-24 years 257 56.7
   25-34 years 130 28.7
   35-44 years 36 7.9
   45-64 years 14 3.1
   Above 65 years 0 0.0
Gender
   Male 140 30.9
   Female 313 69.1
Nationality
   Saudi 391 86.3
   Non-Saudi 62 13.7
Level of education
   High school diploma 68 15.0
   Bachelors 321 70.9
   Post graduate education 64 14.1
Do you have any type of hair loss?
   Yes 410 90.5
   No 43 9.5
What type of hair loss?
   Male pattern hair loss 107 23.6
   Female pattern hair loss 63 13.9
   Telogen effluvium 30 6.6
   Alopecia areata 17 3.8
   Traction areata 1 0.2
I don't know In what form did you use minoxidil? 235 51.9
   Oral 9 2.0
   Liquid solution (drops, spray bottle) 447 98.7
Have you noticed any greying of hair with the use of minoxidil?
   Yes 118 26.0
   No 335 74.0
If yes, how long after using minoxidil?
   3-5 months 62 13.7
   6-8 months 22 4.9
   1 year 15 3.3
   More than 1 year 33 7.3
   Not sure 69 15.2
Have you noticed any other changes in hair color?
   Yes 67 14.8
   No 386 85.2
If yes, what color changes did you notice?
   Light brown 52 11.5
   Orange 9 2.0
   Yellow 4 0.9
   Other 38 8.4
Do you use any other medications for hair loss?
   Yes 89 19.6
   No 364 80.4
Do you have a history of familial greying of the hair?
   Yes 90 19.9
   No 363 80.1

Questionnaires

Survey questions were formulated based on our literature review to include all the reported hair color changes associated with minoxidil use. We also included other greying of hair factors such as age and family history of early greying of hair. It took an average of 2 minutes to complete either of the questionnaires. For validation, a pilot study was conducted on 7 participants to confirm that the questions were well formulated and took an average of 2 minutes to complete. For a full description of the questionnaire, see Appendix.

Ethical consideration

The ethical review board approved the study at Security Forces Hospital, Riyadh, Saudi Arabia. Accreditation number (H-01-R-069). Informed consent was obtained from all participants before filling out the survey.

Statistical analysis

Data were analyzed using Statistical Package for Social Studies (SPSS 22; IBM Corp., New York, NY, USA). Categorical variables were expressed as percentages. chi square test and Fisher exact test were used for categorical variables. A P-value <0.05 was considered statistically significant.

Results

The total number of enrolled patients was 453, most of whom were between 18 and 34 years old. Almost 69.1% were female, and 86.3% were Saudi. Most of the participants have bachelor’s or postgraduate education. 90.5% of the participants have a type of hair loss. Androgenic alopecia accounted for 37.5%. Interestingly, the percentage of greying of hair with the use of topical minoxidil was 26% (n=118). While 14.8% (n=67) noticed other hair color changes. Further demographic characteristics are presented in Table 1.

In addition, we analyzed the patients’ data to seek the changes in hair color that was induced by topical minoxidil; 51.13% of the enrolled patients experienced hair changes while they were on topical minoxidil course. The most common color change that was noticed was lightening of hair color to light brown (46.43%). Most of the patients (92.6%) reported that they were using topical minoxidil for 3-5 months; and during this period, they noticed the color changes. Further details are presented in Tables 2 and 3.

We performed correlation analyses and found that the presence of familial greying history and the duration of the course were two significant factors in inducing hair changes by topical minoxidil, P-value of 0.020, 0.046, respectively. Further details are presented in Table 4.

In addition, we analyzed the dermatologists’ responses to our questionnaire; the total number of dermatologists was 57. Almost 60% of the physicians have ten years or more experience in Dermatology. 42.1% of the physicians noticed greying of hair on their patients after using minoxidil. 17.5% of the physicians think minoxidil caused hair greying, and 10.5% noticed other hair discoloration with minoxidil use. 7% of the other hair color discoloration noticed they were light brown, and 3.5% was orange. Further details are presented in Tables 5 and 6.

Discussion

This study involved analyzing the data of more than 400 patients utilizing minoxidil to establish a consensus on the effect of an unwanted side-effect of a prevalently used medication to treat hair loss. We aimed this study to find the correlation between minoxidil usage and the long-term greying of hair by utilizing a face-validated questionnaire.

Our analysis revealed that most patients currently on topical minoxidil are female in gender, more than 90% are using it to treat their hair loss, and 26% of these patients experienced hair discoloration that started after using topical minoxidil. Further analysis revealed that those with a previous family history of hair greying were the most affected, and those using the medication for more than one year were significantly more affected by hair greying than the rest of the group.

Table 2.

Induced graying of hair of topical minoxidil use by gender (n=453).

Female Male p
Number % Number %
Have you noticed any greying of hair with the use of minoxidil? Yes 84 26.84 34 24.29 0.568
No 229 73.16 106 75.71
If yes, how long after using minoxidil? 3-5 months 45 32.61 17 26.98 0.244
6-8 months 16 11.59 6 9.52
1 year 11 7.97 4 6.35
More than 1 year 17 12.32 16 25.40
Not sure 49 35.51 20 31.75
Have you noticed any other changes in hair color? Yes 50 15.97 17 12.14 0.288
No 263 84.03 123 87.86
If yes, what color changes did you notice? Light brown 39 52.00 13 46.43 0.429
Orange 5 6.67 4 14.29
Yellow 2 2.67 2 7.14
Other 29 38.67 9 32.14
Do you use any other medications for hair loss? Yes 68 21.73 21 15.00 0.096
No 245 78.27 119 85.00
Do you have a history of familial greying of the hair? Yes 58 18.53 32 22.86 0.286
No 255 81.47 108 77.14

Topical minoxidil proved its efficacy in AGA and is currently widely used off-label for other hair loss conditions. Furthermore, the side effects of such a widely used medication are currently being investigated; it is well-established that minoxidil causes minoxidil-induced telogen effluvium, skin irritation, and scaly changes in the scalp. However, very few studies reported a correlation between minoxidil usage and hair color changes.5-9 In the literature, few case reports were published reporting a rare side-effect due to the prolonged usage of minoxidil;10,11 Lyakhovitsky et al. noticed the development of xanthochromia that was mainly attributed to topical minoxidil treatment.10

In addition, Cranwell et al. noticed a marked color change in a patient treated with oral minoxidil for Loose anagen hair syndrome; they postulated that the marked color change could be used as an indicator of the disease resolution. However, the mechanism underlying the marked color change remains unclear to the authors.11 On the other hand, Bublin et al. reported drug-induced hair color changes should only be considered if the patient has no other causes of such a condition. And that the mechanism behind such side-effect is unknown and require further investigation.12

The authors, in their systematic review, classified minoxidil as a drug that requires further confirmatory data to be considered a drug that may induce hair discoloration; Yale et al. conducted a systematic review and proved that the most common causes of hair color changes were stimulators of melanogenesis, vitamin supplementations, and anti-inflammatory medications; their comprehensive systematic review did not report minoxidil as a drug that may induce hair color changes.13

Table 3.

Induced graying of hair of topical minoxidil use by age (n=453).

Variable Under 18 years 18-24 years 25-34 years 35-44 years 45-64 years
Number % Number % Number % Number % Number %
Have you noticed any greying of hair Yes 2 12.50 43 16.73 46 35.38 20 55.56 7 50.000
with the use of minoxidil? No 14 87.50 214 83.27 84 64.62 16 44.44 7 50.000
If yes, how long after using minoxidil? 3-5 months 1 16.67 35 35.00 18 28.13 6 16.67 2 22.222
6-8 months 0 0.00 13 13.00 7 10.94 2 5.56 0 0.000
1 year 0 0.00 3 3.00 6 9.38 4 11.11 2 22.222
More than 1 year 0 0.00 11 11.00 17 26.56 3 8.33 2 22.222
Not sure 5 83.33 38 38.00 16 25.00 7 19.44 3 33.333
Have you noticed any OTHER changes in hair color? Yes 3 18.75 37 14.40 17 13.08 7 19.44 3 21.429
No 13 81.25 220 85.60 113 86.92 29 80.56 11 78.571
If yes, what color changes did you notice? Light brown 3 50.00 29 54.72 13 41.94 5 13.89 2 40.000
Orange 0 0.00 5 9.43 4 12.90 1 2.78 0 0.000
Yellow 0 0.00 2 3.77 1 3.23 0 0.00 0 0.000
Other 3 50.00 17 32.08 13 41.94 2 5.56 3 60.000
Do you use any other medications for hair loss? Yes 3 18.75 45 17.51 29 22.31 8 22.22 4 28.571
No 13 81.25 212 82.49 101 77.69 28 77.78 10 71.429
Do you have a history of familial greying of the hair? Yes 1 6.25 36 14.01 31 23.85 15 41.67 7 50.000
No 15 93.75 221 85.99 99 76.15 21 58.33 7 50.000

Table 4.

Induced graying of hair of topical minoxidil use by educational level.

Variable High school diploma Bachelors Post graduate education p
Number % Number % Number %
Have you noticed any greying of hair Yes 10 14.7 85 26.5 23 35.9 0.020*
with the use of minoxidil? No 58 85.3 236 73.5 41 64.1
If yes, how long after 3-5 months 10 41.7 46 31.5 6 19.4 0.020*
using minoxidil? 6-8 months 1 4.2 19 13.0 2 6.5
1 year 2 8.3 9 6.2 4 12.9
More than 1 year 1 4.2 21 14.4 11 35.5
Not sure 10 41.7 51 34.9 8 25.8
Have you noticed any OTHER Yes 7 10.3 51 15.9 9 14.1 0.491
changes in hair color? No 61 89.7 270 84.1 55 85.9
If yes, what color changes Light brown 6 42.9 40 51.9 6 50.0 0.610
did you notice? Orange 1 7.1 8 10.4 0 0
Yellow 0 0 4 5.2 0 0
Other 7 50.0 25 32.5 6 50.0
Do you use any other medications Yes 12 17.6 66 20.6 11 17.2 0.712
for hair loss? No 56 82.4 255 79.4 53 82.8
Do you have a history of familial Yes 10 14.7 61 19.0 19 29.7 0.046*
greying of the hair? No 58 85.3 260 81.0 45 70.3

*Significant p-value.

We hypothesize that minoxidil could be classified as a drug that potentially induces hair discoloration; however, no original studies, up to our knowledge, provide valuable data to withdraw consensus conclusions. Therefore, we encourage further data to be reported in the literature investigating the ability of minoxidil to induce hair discoloration. Furthermore, the traits associated with the patients who experience hair discoloration must be reported to withdraw valuable conclusions about the potential of this widely used drug to induce the complication, as mentioned earlier.

This study contains a few limitations that must be addressed. First, this study was cross-sectional, which involves the unavoidable limitations of a study design, such as the probability of bias.

Table 5.

Characteristics of the physicians and their opinion about the use of minoxidil (n=57).

Number %
Gender
   Male 27 47.4
   Female 30 52.6
Professional occupation
   Resident 14 24.6
   Assistant consultant 5 8.8
   Consultant 38 66.7
How long have you been practicing dermatology?
   1 year 7 12.3
   2-3 years 6 10.5
   4-5 years 10 17.5
   10 years 20 35.1
   More than 15 years 14 24.6
Have you noticed greying of hair on your patients after using minoxidil?
   Yes 24 42.1
   No 33 57.9
If yes, how long after using minoxidil?
   3-5 months 5 8.8
   6-8 months 4 7.0
   1 year 4 7.0
   More than 1 year 1 1.8
   Not sure 8 14.0
Do you think minoxidil caused the greying of hair?
   Yes 10 17.5
   No 2 3.5
   Not sure 10 17.5
If greying of hair was noted, which formulation was used by the patient?
   Oral 1 1.8
   Liquid solution 21 36.8
Did you notice any OTHER hair discoloration with minoxidil use?
   Yes 6 10.5
   No 47 82.5
If Yes, what color did you notice?
   Light brown 4 7.0
   Orange 2 3.5

Table 6.

Opinion of the physicians by their professional occupation.

Variable Resident Assistant consultant Consultant p
Number % Number % Number %
Have you noticed greying of hair on your patients Yes 8 57.1 3 60.0 13 34.2 0.231
after using minoxidil? No 6 42.9 2 40.0 25 65.8
If yes, how long after using minoxidil? 3-5 months 3 42.9 2 16.7 0.559
6-8 months 1 33.3 3 25.0
1 year 2 28.6 2 16.7
>1 Year 1 8.3
Not sure 2 28.6 2 66.7 4 33.3
Do you think minoxidil caused the greying of hair? Yes 4 57.1 2 66.7 4 33.3 0.670
No 1 14.3 1 8.3
Not sure 2 28.6 1 33.3 7 58.3

Second, the questionnaire utilized was only face-validated and was revised by experts in the field of dermatology; yet, not utilizing a validated questionnaire is a limitation of this study. Third, we only surveyed the patients in the kingdom of Saudi Arabia and Middle Eastern in ethnicity; therefore, the results presented could not apply to other ethnicities, including Caucasians, Asians, and Hispanics. Nevertheless, this study may be a stepping stone in encouraging further reported data about the effect of minoxidil in inducing hair discoloration.

Conclusions

In our study, although minoxidil is a safe and well-tolerated medication, undesirable side effect such as change in hair pigmentation have been reported by many patients and dermatologist. Greying of the hair was the most common color noticed by participants, followed by different shades of brown and yellow. Our finding suggests a possible association between changes in hair pigmentation and minoxidil. Therefore, dermatologists should be mindful of this adverse event as to educate patients about it. Nonetheless, more research is required to develop a deeper understanding of such relationship.

Acknowledgments

This project was approved from the Institutional Review Board at Security Forces Hospital. Accreditation number (H-01-R-069).

Funding Statement

Funding: none.

References

  • 1.Mundt HM, Matenaer M, Lammert A, et al. Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis. J Clin Hypertens (Greenwich) 2016;18:1162-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review [published correction appears in Drug Des Devel Ther 2020;14:575]. Drug Des Devel Ther 2019;13:2777-86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Lachgar S, Charveron M, Gall Y, Bonafe JL. Minoxidil upreg-ulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. Br J Dermatol 1998;138:407-11. [DOI] [PubMed] [Google Scholar]
  • 4.Shorter K, Farjo NP, Picksley SM, Randall VA. Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil. FASEB J 2008;22:1725-36. [DOI] [PubMed] [Google Scholar]
  • 5.Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review [published correction appears in Drug Des Devel Ther 2020;14:575]. Drug Des Devel Ther 2019;13:2777-86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Randolph M, Tosti A. Oral minoxidil treatment for hair loss: A review of efficacy and safety. J Am Acad Dermatol 2021;84:737-46. [DOI] [PubMed] [Google Scholar]
  • 7.Gupta AK, Talukder M, Venkataraman M, Bamimore MA. Minoxidil: a comprehensive review. J Dermatolog Treat 2022;33:1896-906. [DOI] [PubMed] [Google Scholar]
  • 8.Stoehr JR, Choi JN, Colavincenzo M, Vanderweil S. Off-Label Use of Topical Minoxidil in Alopecia: A Review. Am J Clin Dermatol 2019;20:237-50. [DOI] [PubMed] [Google Scholar]
  • 9.Sharma AN, Michelle L, Juhasz M, et al. Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review. Int J Dermatol 2020;59:1013-9. [DOI] [PubMed] [Google Scholar]
  • 10.Yakhovitsky A, Warshavsky K, Ben Mordechai Y, et al. Harefuah 2020;159:6-10. [PubMed] [Google Scholar]
  • 11.Cranwell WC, Sinclair R. Loose anagen hair syndrome: Treatment with systemic minoxidil characterised by marked hair colour change. Australas J Dermatol 2018;59:e286-e287. [DOI] [PubMed] [Google Scholar]
  • 12.Bublin JG, Thompson DF. Drug-induced hair colour changes. J Clin Pharm Ther 1992;17:297-302. [DOI] [PubMed] [Google Scholar]
  • 13.Yale K, Juhasz M, Atanaskova Mesinkovska N. Medication-Induced Repigmentation of Gray Hair: A Systematic Review. Skin Appendage Disord 2020;6:1-10. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Dermatology Reports are provided here courtesy of PAGEPress

RESOURCES